GLABF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 4 cases where GLABF's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where GLABF's RSI Indicator exited the oversold zone, of 8 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on December 27, 2024. You may want to consider a long position or call options on GLABF as a result. In of 21 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for GLABF just turned positive on December 31, 2024. Looking at past instances where GLABF's MACD turned positive, the stock continued to rise in of 12 cases over the following month. The odds of a continued upward trend are .
GLABF moved above its 50-day moving average on December 24, 2024 date and that indicates a change from a downward trend to an upward trend.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Aroon Indicator for GLABF entered a downward trend on January 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (14.744). P/E Ratio (0.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). GLABF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (264.079).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GLABF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GLABF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Industry Biotechnology
A.I.dvisor indicates that over the last year, GLABF has been loosely correlated with ELVAF. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if GLABF jumps, then ELVAF could also see price increases.
Ticker / NAME | Correlation To GLABF | 1D Price Change % | ||
---|---|---|---|---|
GLABF | 100% | N/A | ||
ELVAF - GLABF | 36% Loosely correlated | N/A | ||
TNFA - GLABF | 29% Poorly correlated | -2.52% | ||
IDRSF - GLABF | 23% Poorly correlated | N/A | ||
VYGR - GLABF | 22% Poorly correlated | +0.20% | ||
ENTO - GLABF | 8% Poorly correlated | +2.25% | ||
More |